Skip to main content

Table 3 Chemotherapy details

From: Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis

Characteristics CRT group Referent group
NAC (%) N=15 CC (%) N1=45, N2=56 AC (%) N=12 NAC (%) N=15 CC (%) N1=51, N2=50 AC (%) N=12
Cycles       
3-weekly regimen       
1 8 (53.3) 5 (11.1) 7 (58.3) 6 (40.0) 5 (9.8) 7 (58.3)
2 7 (46.7) 26 (57.8) 5 (41.7) 9 (60.0) 30 (58.8) 5 (41.7)
3 0 (0.0) 14 (31.1) 0 (0.0) 0 (0.0) 16 (31.4) 0 (0.0)
Weekly regimen       
5 0 (0) 23 (41.1) 0 (0) 0 (0) 20 (40.0) 0 (0)
6 0 (0) 22 (39.3) 0 (0) 0 (0) 19 (38.0) 0 (0)
7 0 (0) 11 (19.6) 0 (0) 0 (0) 11 (22.0) 0 (0)
Dose modification 3 (20.0) 21 (20.8) 4 (33.3) 2 (13.3) 4 (4.0) 2 (16.7)
  1. Abbreviations: NAC, Neo-adjuvant chemotherapy; CC, Concurrent chemoerapy; AC, Adjuvant chemotherapy.